Global Footprint
Global Shift
The legalization of medical and recreational marijuana in Canada has polarized the country and garnered the attention of foreign governments around the world, and where there is currently a global shift towards the general acceptance of cannabis as a legitimate alternative to conventional prescription-based drugs.
Global Leadership
Canada is currently the only G7 country to fully legalize marijuana and NSBG believes that this provides domestic players a first-mover advantage to supply and serve international markets. NSBG is aggressively seizing this unique opportunity to establish a global leadership role in the industry at a time when many jurisdictions are considering legalizing cannabis.
Canada
With headquarters and main production facilities located in Canada, NSBG is well positioned to serve the North American market.
Europe
NSBG is presently in open discussions with European companies (i.e. Netherlands, Greece etc.) with the intent to replicate Canadian cannabis industry success through strategic acquisitions and joint ventures.
Israel
NSBG has established partnerships with Israeli labs, which have extensive cannabis product development and R&D experience.
Canada
With headquarters and main production facilities located in Canada, NSBG is well positioned to serve the North American market.
Europe
NSBG is presently in open discussions with European companies (i.e. Netherlands, Greece etc.) with the intent to replicate Canadian cannabis industry success through strategic acquisitions and joint ventures.
Israel
NSBG has established partnerships with Israeli labs, which have extensive cannabis product development and R&D experience.